The Inter-Agency Task Force for the Management of Emerging Infectious Diseases has approved the collaboration with five coronavirus disease 2019 (Covid-19) vaccine manufacturers from China and Taiwan to be used in clinical trials in the country.
The manufacturers are Chinese Academy of Science-Guangzhou Institute of Biomedicine and Health, Sinopharm-Wuhan Institute and Beijing Biologicals Institute and Sinovac Biotech Ltd. of China, and Adimmune Corp. and Academia Sinica of Taiwan.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.